Barry is a biomedical scientist who gets a lot of attention for his work, specifically as it relates to diabetes management. He was invited to speak on "Transcriptional Control of Lipid Homeostasis" at a closed conference hosted by the Nobel Assembly of the Karolinska Institute. And he received the 2005 American Society for Biochemistry and Molecular Biology (ASBMB)-AMGEN award, recognizing new investigators for significant achievements in the application of biochemistry and molecular biology to disease understanding. He's also been recognized as a postdoctoral mentor by the American Diabetes Association.
He received his MD and PhD as part of the NIH Medical Scientist Training Program at New York University School of Medicine, and was awarded a postdoctoral fellowship at the Salk Institute for Biological Sciences. He also served on the steering committee for the NIH's Nuclear Receptor Signaling Atlas (NURSA) to provide a common reference for genomic and proteomic research—like that conducted at MetaProteomics.
He holds 15 patents, with additional patents pending, primarily in the areas of insulin signaling and PPAR transcription factors.